TY - JOUR
T1 - Obesity Does Not Impact Outcomes or Rates of Gastroesophageal Reflux after Peroral Endoscopic Myotomy in Achalasia
AU - Sanaka, Madhusudhan R.
AU - Parikh, Malav P.
AU - Subramanium, Subanandhini
AU - Thota, Prashanthi N.
AU - Gupta, Niyati M.
AU - Lopez, Rocio
AU - Gabbard, Scott
AU - Murthy, Sudish
AU - Raja, Siva
N1 - Publisher Copyright:
© 2018 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2020/4/1
Y1 - 2020/4/1
N2 - Background:Outcomes of laparoscopic Heller myotomy in obese patients with achalasia are suboptimal along with the increased risk of gastroesophageal reflux disease (GERD). The impact of obesity on treatment success and GERD after peroral endoscopic myotomy (POEM) are not well known. Hence, our study aims were to compare the clinical outcomes and rates of GERD after POEM in nonobese versus obese patients with achalasia.Methods:Chart review of all achalasia patients who underwent POEM at our institution between April 2014 and June 2018. Patients with timed barium esophagram (TBE) and high-resolution esophageal manometry (HREM) before POEM along with post-POEM TBE, HREM, and esophageal pH study were included. Patients were categorized into 2 groups, nonobese (body mass index <30 kg/m2) and obese (body mass index ≥30 kg/m2). Patient demographics, TBE, HREM, pH study findings, and Eckardt scores were compared between the 2 groups.Results:A total of 89 patients (46 nonobese; 43 obese) met the study criteria. There were no significant differences in age, gender, achalasia subtype, operative time, length of stay and complication rates between the 2 groups. Treatment success (Eckardt score ≤3) was similar in both groups (97.7% nonobese vs. 92.7% obese, P=0.35). Abnormal DeMeester scores on pH study (>14.72) were similar in nonobese and obese patients (58.7% vs. 46.5%, P=0.25). Symptomatic GERD was also similar in both groups (17.8% in nonobese vs. 20% in obese, P=0.79).Conclusions:POEM is an equally safe and effective treatment option for both nonobese and obese patients with achalasia in the short-term. Interestingly, POEM does not lead to higher rates of GERD in obese compared with nonobese patients.
AB - Background:Outcomes of laparoscopic Heller myotomy in obese patients with achalasia are suboptimal along with the increased risk of gastroesophageal reflux disease (GERD). The impact of obesity on treatment success and GERD after peroral endoscopic myotomy (POEM) are not well known. Hence, our study aims were to compare the clinical outcomes and rates of GERD after POEM in nonobese versus obese patients with achalasia.Methods:Chart review of all achalasia patients who underwent POEM at our institution between April 2014 and June 2018. Patients with timed barium esophagram (TBE) and high-resolution esophageal manometry (HREM) before POEM along with post-POEM TBE, HREM, and esophageal pH study were included. Patients were categorized into 2 groups, nonobese (body mass index <30 kg/m2) and obese (body mass index ≥30 kg/m2). Patient demographics, TBE, HREM, pH study findings, and Eckardt scores were compared between the 2 groups.Results:A total of 89 patients (46 nonobese; 43 obese) met the study criteria. There were no significant differences in age, gender, achalasia subtype, operative time, length of stay and complication rates between the 2 groups. Treatment success (Eckardt score ≤3) was similar in both groups (97.7% nonobese vs. 92.7% obese, P=0.35). Abnormal DeMeester scores on pH study (>14.72) were similar in nonobese and obese patients (58.7% vs. 46.5%, P=0.25). Symptomatic GERD was also similar in both groups (17.8% in nonobese vs. 20% in obese, P=0.79).Conclusions:POEM is an equally safe and effective treatment option for both nonobese and obese patients with achalasia in the short-term. Interestingly, POEM does not lead to higher rates of GERD in obese compared with nonobese patients.
KW - achalasia
KW - gastroesophageal reflux disease
KW - obesity
KW - peroral endoscopic myotomy
UR - http://www.scopus.com/inward/record.url?scp=85069488278&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85069488278&partnerID=8YFLogxK
U2 - 10.1097/MCG.0000000000001235
DO - 10.1097/MCG.0000000000001235
M3 - Article
C2 - 31306345
AN - SCOPUS:85069488278
SN - 0192-0790
VL - 54
SP - 338
EP - 343
JO - Journal of clinical gastroenterology
JF - Journal of clinical gastroenterology
IS - 4
ER -